These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22820011)

  • 21. A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation.
    Jiang L; Xu Y; Liu Q; Tang Y; Ge L; Zheng C; Zhu J; Liu J
    Int J Pharm; 2013 Feb; 443(1-2):80-6. PubMed ID: 23291446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
    Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albumin-based nanoparticles as potential controlled release drug delivery systems.
    Elzoghby AO; Samy WM; Elgindy NA
    J Control Release; 2012 Jan; 157(2):168-82. PubMed ID: 21839127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
    Pawar AA; Chen DR; Venkataraman C
    Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation.
    Teng Z; Luo Y; Wang Q
    J Agric Food Chem; 2012 Mar; 60(10):2712-20. PubMed ID: 22352467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein based nanoparticles as platforms for aspirin delivery for ophthalmologic applications.
    Das S; Bellare JR; Banerjee R
    Colloids Surf B Biointerfaces; 2012 May; 93():161-8. PubMed ID: 22305122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and physicochemical characterization of a novel paclitaxel-loaded amphiphilic aminocalixarene nanoparticle platform for anticancer chemotherapy.
    Weeden C; Hartlieb KJ; Lim LY
    J Pharm Pharmacol; 2012 Oct; 64(10):1403-11. PubMed ID: 22943171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug delivery.
    Liang P; Zhao D; Wang CQ; Zong JY; Zhuo RX; Cheng SX
    Colloids Surf B Biointerfaces; 2013 Feb; 102():783-8. PubMed ID: 23104038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein-coated nanoparticles embedded in films as delivery platforms.
    Morales JO; Ross AC; McConville JT
    J Pharm Pharmacol; 2013 Jun; 65(6):827-38. PubMed ID: 23647676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly(lactide-co-glycolide) nanoparticles.
    McCarron PA; Hall M
    Int J Pharm; 2008 Feb; 348(1-2):115-24. PubMed ID: 17709217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting.
    Kolluru LP; Rizvi SA; D'Souza M; D'Souza MJ
    J Drug Target; 2013 Jan; 21(1):77-86. PubMed ID: 23036042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
    Subia B; Kundu SC
    Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
    Wacker M; Zensi A; Kufleitner J; Ruff A; Schütz J; Stockburger T; Marstaller T; Vogel V
    Int J Pharm; 2011 Jul; 414(1-2):225-32. PubMed ID: 21571055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
    Yang B; Shen M; Liu J; Ren F
    Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles.
    Glangchai LC; Caldorera-Moore M; Shi L; Roy K
    J Control Release; 2008 Feb; 125(3):263-72. PubMed ID: 18053607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil.
    Santhi K; Dhanaraj SA; Joseph V; Ponnusankar S; Suresh B
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1171-9. PubMed ID: 12455476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.